The Strüngmann brothers, founders of German drug manufacturer Hexal, have secured a 25% stake in eHealth specialists InterComponentWare.
The deal has been completed after the Strüngmann’s investment company, Santo Holding, purchased newly issued shares from ICW’s recent increase in capital stock.
Existing shareholders will not have to surrender any shares as part of the deal, with the company looking to invest the newly acquired funds into further expansion in the international eHealth market.
The best known existing investor in the company is SAP AG co-founder Dietmar Hopp.
ICW’s CEO Peter Reuschel, said in a press statement: “The trust of our new investors in ICW shows that we are pursuing the right strategy and that our solutions have a large national and international market potential.”
Currently, ICW is pursuing two strategic approaches to improving communication, quality and efficiency in the healthcare market.
The first is supporting the introduction of secure health care IT infrastructures internationally including Bulgaria’s electronic health card project and a research project for German insurance group Barmer.
The second is networking medical professionals together in their medical bases. This includes recent work in the German states of Bavaria.
The Strüngmann brothers said of their investment: “We opted for an investment in ICW, because it is in a perfect position to assert itself in the high-growth global eHealth market with its open platform approach and mature solutions.
“With its networking solutions, ICW has the potential to make the national and global health care market more efficient. We want to support and accompany the process.”